Key Insights

Highlights

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Enrolling By Invitation1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01186913Enrolling By Invitation

Natural History Study of SCID Disorders

Showing all 1 trials

Research Network

Active Sponsors

  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • National Center for Advancing Translational Sciences (NCATS)1
  • Primary Immune Deficiency Treatment Consortium (PIDTC)1
  • Office of Rare Diseases (ORD)1

Top Investigators

Related Conditions

  • Xscid1
  • Omenn Syndrome1
  • Reticular Dysgenesis1
  • Leaky Scid1
  • Severe Combined Immunodeficiency Scid1

Activity Timeline